CME Group Inc.SEC Filings
|
|
All SEC filings by CME Group Inc. (CME) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 24, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 24, 2026 | |
| ARS | Annual report to shareholders | Mar 23, 2026 | ||
| 10-K | Annual report | View Diff | Feb 26, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 24, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 24, 2025 | |
| 10-Q | Quarterly report | View Diff | Apr 30, 2025 | |
| ARS | Annual report to shareholders | Mar 20, 2025 | ||
| 10-K | Annual report | View Diff | Feb 27, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 8, 2024 |
Events
| 8-K | Current report | Aug 11, 2026 | ||
| 8-K | Cme Group Inc. Reports Strong Financial Results for Q2 2026 | Jul 22, 2026 | ||
| 8-K | Current report | Jun 17, 2026 | ||
| 8-K | Current report | Jun 10, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 19, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Apr 27, 2026 | ||
| 8-K | Cme Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026 | Apr 22, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Feb 4, 2026 | ||
| 8-K | Regulation Fd Disclosure | Feb 2, 2026 | ||
| 8-K | Cme Group Inc. Announces Third-Quarter 2025 Financial Results | Oct 22, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Mar 13, 2026 | ||
| 424B5 | Prospectus supplement for primary offering | Mar 4, 2025 | ||
| FWP | Free writing prospectus | Mar 3, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Mar 3, 2025 | ||
| S-3ASR | Automatic shelf registration | Mar 3, 2025 | ||
| S-8 | Registration of securities for employees | Jun 9, 2022 | ||
| 424B5 | Prospectus supplement for primary offering | Mar 3, 2022 | ||
| FWP | Free writing prospectus | Mar 1, 2022 | ||
| 424B5 | Prospectus supplement for primary offering | Mar 1, 2022 | ||
| S-3ASR | Automatic shelf registration | Mar 1, 2022 |
Proxies
| DEFA14A | Additional proxy soliciting materials | May 19, 2026 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 15, 2026 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 23, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 23, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Mar 12, 2026 | ||
| PRE 14A | Preliminary proxy | Mar 12, 2026 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 24, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 20, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 20, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Mar 21, 2024 |
Other
| UPLOAD | Letter from SEC | Oct 25, 2022 | ||
| CORRESP | Correspondence with SEC | Sep 30, 2022 | ||
| UPLOAD | Letter from SEC | Sep 21, 2022 | ||
| UPLOAD | Letter from SEC | Dec 23, 2019 | ||
| CORRESP | Correspondence with SEC | Dec 19, 2019 | ||
| UPLOAD | Letter from SEC | Dec 5, 2019 | ||
| CORRESP | Correspondence with SEC | Feb 28, 2019 | ||
| EFFECT | Notice of effectiveness | Dec 24, 2014 | ||
| UPLOAD | Letter from SEC | Jul 16, 2014 | ||
| CORRESP | Correspondence with SEC | Jul 1, 2014 |